<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1796</number>
    <updateDate>2025-11-19T03:34:09Z</updateDate>
    <updateDateIncludingText>2025-11-19T03:34:09Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2025-03-03</introducedDate>
    <congress>119</congress>
    <legislationUrl>https://www.congress.gov/bill/119th-congress/house-bill/1796</legislationUrl>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 171, Number 40 (Monday, March 3, 2025)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. JAMES:H.R. 1796.Congress has the power to enact this legislation pursuantto the following:Pursuant to Clause 7(c)(1) of Rule XII of the Rules of theHouse of Representatives, the constitutional authority forenacting this legislation is found in Article I, Section 8 ofthe United States Constitution, specifically:Article I, Section 8, Clause 1: The General Welfare Clause,which grants Congress the power to provide for the generalwelfare of the United States, including promoting publichealth initiatives.Article I, Section 8, Clause 3: The Commerce Clause, whichgrants Congress the authority to regulate commerce among theseveral states, including the regulation of healthcareservices and programs that impact interstate commerce.Article I, Section 8, Clause 18: The Necessary and ProperClause, which grants Congress the authority to enact lawsnecessary and proper for carrying out its enumerated powers,including the implementation of public health programs toaddress diseases such as sickle cell disease.[Page H946]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2025-03-03T17:01:50Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Bipartisan Health Care Act</title>
        <congress>119</congress>
        <number>891</number>
        <type>S</type>
        <latestAction>
          <actionDate>2025-03-06</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025</title>
        <congress>119</congress>
        <number>735</number>
        <type>S</type>
        <latestAction>
          <actionDate>2025-02-26</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Lower Costs for Everyday Americans Act</title>
        <congress>119</congress>
        <number>1768</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2025-03-03</actionDate>
          <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2025-03-03</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2025-03-03</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-03-03</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>J000307</bioguideId>
        <fullName>Rep. James, John [R-MI-10]</fullName>
        <firstName>John</firstName>
        <lastName>James</lastName>
        <party>R</party>
        <state>MI</state>
        <district>10</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>V000131</bioguideId>
        <fullName>Rep. Veasey, Marc A. [D-TX-33]</fullName>
        <firstName>Marc</firstName>
        <lastName>Veasey</lastName>
        <party>D</party>
        <state>TX</state>
        <middleName>A.</middleName>
        <district>33</district>
        <sponsorshipDate>2025-03-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001125</bioguideId>
        <fullName>Rep. Carter, Troy A. [D-LA-2]</fullName>
        <firstName>Troy</firstName>
        <lastName>Carter</lastName>
        <party>D</party>
        <state>LA</state>
        <middleName>A.</middleName>
        <district>2</district>
        <sponsorshipDate>2025-03-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000096</bioguideId>
        <fullName>Rep. Davis, Danny K. [D-IL-7]</fullName>
        <firstName>Danny</firstName>
        <lastName>Davis</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>K.</middleName>
        <district>7</district>
        <sponsorshipDate>2025-03-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>K000399</bioguideId>
        <fullName>Rep. Kiggans, Jennifer A. [R-VA-2]</fullName>
        <firstName>Jennifer</firstName>
        <lastName>Kiggans</lastName>
        <party>R</party>
        <state>VA</state>
        <middleName>A.</middleName>
        <district>2</district>
        <sponsorshipDate>2025-03-03</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>V000138</bioguideId>
        <fullName>Rep. Vindman, Eugene Simon [D-VA-7]</fullName>
        <firstName>Eugene</firstName>
        <lastName>Vindman</lastName>
        <party>D</party>
        <state>VA</state>
        <middleName>Simon</middleName>
        <district>7</district>
        <sponsorshipDate>2025-08-15</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Blood and blood diseases</name>
          <updateDate>2025-07-24T17:58:11Z</updateDate>
        </item>
        <item>
          <name>Genetics</name>
          <updateDate>2025-07-24T17:58:11Z</updateDate>
        </item>
        <item>
          <name>Health promotion and preventive care</name>
          <updateDate>2025-07-24T17:58:11Z</updateDate>
        </item>
        <item>
          <name>Hereditary and development disorders</name>
          <updateDate>2025-07-24T17:58:11Z</updateDate>
        </item>
        <item>
          <name>Medical research</name>
          <updateDate>2025-07-24T17:58:11Z</updateDate>
        </item>
        <item>
          <name>Research administration and funding</name>
          <updateDate>2025-07-24T17:58:11Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2025-03-19T16:05:14Z</updateDate>
      </policyArea>
    </subjects>
    <title>Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025</title>
        <updateDate>2025-03-19T03:08:20Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025</title>
        <updateDate>2025-03-19T03:08:19Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.</title>
        <updateDate>2025-03-19T03:03:28Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2025-03-03T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119hr1796ih/xml/BILLS-119hr1796ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2025-03-03</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
